Overview
Atypical mycobacterial infections are often acquired through environmental exposures, particularly water, and can affect various organs including skin, heart devices, and uncommon sites like breast tissue in immunocompromised individuals such as those on hemodialysis 14.Diagnosis
Clinical suspicion: High index of suspicion, especially in immunocompromised patients and those with recent surgical procedures 1.
Diagnostic techniques: Utilize Auramine-Rhodamine staining and PCR for rapid detection and drug susceptibility testing 1.
Laboratory diagnostics: Employ molecular diagnostics like MALDI-TOF for accurate identification 1.
Specific contexts: Consider mycobacterial infection in patients with implantable cardiac devices or post-cardiopulmonary bypass surgery 23.Management
First-line treatments: Specific antimycobacterial agents based on susceptibility testing; no specific doses mentioned in abstracts 1.
Adjunctive therapies: Surgical intervention may be necessary for device infections or severe localized infections 23.
Supportive care: Tailored to the patient's overall health status, particularly important in immunocompromised individuals 4.Special Populations
Immunocompromised: Increased vigilance required due to higher susceptibility 14.
Haemodialysis patients: Recognize atypical presentations, such as breast infections 4.
Post-surgical patients: Enhanced focus on prevention and early detection post-cardiopulmonary bypass surgery 2.Key Recommendations
Maintain high clinical suspicion for atypical mycobacterial infections, especially in immunocompromised and post-surgical patients (Evidence: Expert opinion) 124.
Implement advanced diagnostic methods including molecular diagnostics for accurate identification and susceptibility testing (Evidence: Moderate) 1.
Strengthen infection control practices in healthcare settings to prevent surgical site infections related to inadequate sterilization (Evidence: Expert opinion) 1.References
1 Barker C, Alshaikh H, Elston D. Dermatology practice updates in mycobacterial disease. International journal of dermatology 2024. link
2 Hasse B, Hannan MM, Keller PM, Maurer FP, Sommerstein R, Mertz D et al.. International Society of Cardiovascular Infectious Diseases Guidelines for the Diagnosis, Treatment and Prevention of Disseminated Mycobacterium chimaera Infection Following Cardiac Surgery with Cardiopulmonary Bypass. The Journal of hospital infection 2020. link
3 Luckie M, Zaidi A, Woodhead M, Garratt C. Mycobacterium tuberculosis causing infection of an implantable biventricular defibrillator. The Indian journal of tuberculosis 2010. link
4 Modai D, Weissgarten J, Reiff R, Siegal B, Gabizon D. Breast mycobacterial infection in a haemodialysis patient. Postgraduate medical journal 1984. link